Pharmacogenomics Access & Reimbursement Coalition
Company

Pharmacogenomics Access & Reimbursement Coalition

Biotechnology Research Payer Issues 2 employees
Employees
2
Contacts
1
Emails
1

Pharmacogenomics Access & Reimbursement Coalition Overview

Headquarters
Payer Issues
Industry
Biotechnology Research
Employees
2
Founded
2018
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Pharmacogenomics Access & Reimbursement Coalition

Adoption of personalized medicine in practice has been slow, in part due to the lack of payer adoption of these technologies. Coverage by insurers is a critical step in achieving widespread adoption of personalized medicine. Insurers consider a variety of factors when formulating medical coverage policies for personalized medicine, including the overall strength of evidence for a test, availability of clinical guidelines and health technology assessments by independent organizations. The Pharmacogenomics Access & Reimbursement Coalition seeks to bring together resources to address payer issues, which pose a barrier for the widespread implementation of pharmacogenetic testing.

Pharmacogenomics Access & Reimbursement Coalition Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

Pharmacogenomics Access & Reimbursement Coalition Org Chart

Sample employees and titles
Name Title Contact
Sara Rogers Pharmacist, Researcher, Director
Email

Compare Similar Companies to Pharmacogenomics Access & Reimbursement Coalition